The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > APBiotech Inc

APBiotech Inc
 PROFILE
APBiotech helps scientists and drugmakers blaze a new trail in biotechnology. The firm, a joint venture of Amersham (formerly Nycomed Amersham, which owns 55%) and Pharmacia (45%), makes equipment and supplies for biotechnology, drug development, and gene sequencing research. Its products include MegaBACE automated DNA sequencers; chromatographic systems to purify insulin, vaccines, and proteins; protein-labeling systems; and microassays. As biotechnology expands, so does the firm; it joined The SNP Consortium to map DNA variations that create individuality. With IPOs in a slump, Amersham has put on hold plans to list 10% of its stake in APBiotech on the Nasdaq.

 COMPETITION
Agilent Technologies, Inc. (A)
Applera Corporation (dossier)
Bio-Rad Laboratories, Inc. (BIO)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 864.10
1-Yr. Sales Growth: 18.5%
Employees: 4,200
Revenue per employee: $205,738.10

 KEY PEOPLE
• Andrew Carr
    CEO
• Sandra Cartie
    CFO

 CONTACT INFO
SE-751 84
Uppsala, Sweden
Phone: 46-18 -0 00
Fax: 46-18 -2 00
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001